Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Testosterone improves mood and thinking skills; finasteride has no effect.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Orlistat might block the body's ability to absorb thyroid medication.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Hair loss in postmenopausal woman caused by ovarian issue.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

PTH-CBD helps reduce hair loss in mice by stimulating hair growth directly.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Check and treat low iron and vitamin D levels in people with hair loss.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Hormones during puberty increase certain receptors in the brain, and this change is influenced by estrogen levels.

Testosterone reduces key molecules needed for early pregnancy in rats.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

The healthcare for transgender veterans could be better with a more unified team approach.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.